Advertisement

Topics

Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery

2017-10-30 21:47:10 | BioPortfolio

Published on BioPortfolio: 2017-10-30T21:47:10-0400

Clinical Trials [7657 Associated Clinical Trials listed on BioPortfolio]

Effect of Radiation and Its Timing on Breast Reconstruction in Chinese Patients

The purpose of the study is to investigate the impacts of radiation and the timing of radiation on autologous and prosthetic-based breast reconstruction in Chinese post-mastectomy breast c...

Radiation Therapy in Treating Patients With Recurrent Breast Cancer

RATIONALE: Radiation therapy uses high-energy x-rays and other types of radiation to kill tumor cells. It is not yet known whether a single dose of radiation therapy is more effective than...

Cosmetic Outcome, Patient-reported Outcomes, and Reconstruction-related Complications in Breast Cancer Women Treated With or Without Post-mastectomy Radiation Therapy: Prospective Cohort Study

This study aim to investigate the breast reconstruction outcome after mastectomy with or without radiation therapy from the patient's point of view.

Eliminating Breast Cancer Surgery in Exceptional Responders With Neoadjuvant Therapy

The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been treated with chemotherapy and have had...

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

This randomized phase II trial studies how well hypofractionated radiation therapy works in preventing the return of tumor cells in breast cancer patients following surgery. Hypofractionat...

PubMed Articles [26486 Associated PubMed Articles listed on BioPortfolio]

Influence of the subtype on local recurrence risk of breast cancer with or without radiation therapy.

To investigate if intrinsic subtypes of breast cancer predict different risks of ipsilateral breast tumor recurrence (IBTR) following breast-conserving surgery (BCS) with and without postoperative rad...

Mebendazole potentiates radiation therapy in triple-negative breast cancer.

The lack of a molecular target in triple negative breast cancer (TNBC) makes it one of the most challenging breast cancers to treat. Radiation therapy (RT) is an important treatment modality for manag...

Risk of cardiac disease after adjuvant radiation therapy among breast cancer survivors.

Adjuvant radiation therapy (RT) for breast cancer is associated with heart disease, although the impact of patient-specific factors on the interaction between cardiac risk and RT is not well-studied i...

Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer.

Advanced cancer has been shown to be associated with a higher percentage of epigenetic changes than with genetic mutations. Preclinical models have shown that the combination of paclitaxel, sorafenib,...

Local-therapy decisional regret in older women with breast cancer: A population-based study.

Older women with non-metastatic breast cancer can often choose among several surgery and radiation treatment options. Little is known regarding how these choices contribute to decisional regret, which...

Medical and Biotech [MESH] Definitions

Abnormal accumulation of lymph in the arm, shoulder and breast area associated with surgical or radiation breast cancer treatments (e.g., MASTECTOMY).

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.

Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).

More From BioPortfolio on "Hypofractionated Radiation Therapy With Concomitant Boost in Treating Women After Breast Conserving Surgery"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial